by Jordana Choucair | Mar 1, 2022 | Life Sciences
The U.S. Patent and Trademark Office ruled that the Broad Institute of MIT and Harvard owns the rights to the genome editing technology CRISPR. The decision invalidates patent rights UC Berkeley granted gene-editing companies developing human therapies. It also means...
by Jordana Choucair | Mar 1, 2022 | Opioid/Substance Use Disorders
Lawyers for two doctors convicted of illegal opioid prescribing will ask the Supreme Court to overturn the doctors’ convictions and establish a standard that allows doctors to raise a “good faith” defense. Juries could then consider whether doctors...
by Jordana Choucair | Mar 1, 2022 | Payers
Cigna announced it plans to invest $450 million in its venture capital arm as part of its strategy to increase the company’s shareholder value and deliver long-term growth. The company will focus on contributing to bolt-on or tuck-in acquisitions along with...
by Jordana Choucair | Mar 1, 2022 | Providers
A working paper from the National Bureau of Economic Research found that receiving care from an expensive hospital in a concentrated market increases spending but has no detectable effect on mortality. However, the relationship between higher prices and lower...
by Jordana Choucair | Mar 1, 2022 | Public Health/Prevention
HHS released a report outlining its efforts to make the make the public health supply chains and biological preparedness industrial base more resilient, diverse, and secure. The report explores the public health supply chain and industrial base’s vulnerabilities and...
Recent Comments